[18F]FDG/PET: a non-invasive technique for the study of stroke in murine and rat models
DOI:
https://doi.org/10.15392/2319-0612.2023.2240Keywords:
Positron Emission Tomography, [18F]FDG, Murine and Rat Stroke Models, StrokeAbstract
The use of mouse and rat models in conjunction with anatomic functional imaging techniques has directly contributed to expanding knowledge about the complex pathophysiology of stroke. Therefore, this study aims to identify the most relevant mouse and rat models of stroke and how [18F]FDG/PET can contribute to this pathology study. A narrative review of the literature was performed to describe applications of positron emission tomography in conjunction with the radiopharmaceutical [18F]FDG in stroke models. PubMed, Scopus, and Web of Science were searched for relevant articles published between 2015 and 2022. In this study, we describe applications of positron emission tomography in combination with the radiopharmaceutical [18F]FDG in mouse and rat stroke models. The most commonly used model was middle cerebral artery occlusion (MCAO) in rats. This study demonstrates that using murine and rat models in conjunction with anatomic functional imaging techniques has directly contributed to expanding knowledge about the complex pathophysiology of stroke. In addition, they have been essential for studies aimed at discovering and developing therapeutic and prophylactic strategies for the disease.
Downloads
References
FEIGIN, V. L., et al. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019, The Lancet Neurology, v. 20, n. 1, p. 795-820, 2021.
KATAN, M., et al. Global Burden of Stroke, Semin Neurol, v. 38, n. 2, p. 208-211, 2018.
LANCELOT, S., et al. Small-animal positron emission tomography as a tool for neuropharmacology, Trends Pharmacol Sci, v. 31, n. 4, p. 411-417, 2010.
SOMMER, C. J. Ischemic stroke: experimental models and reality, Acta Neuropathol, v. 133, n. 5, p. 245-261, 2017.
OJAGHIHAGHIGHI, S., et al. Comparison of neurological clinical manifestation in patients with hemorrhagic and ischemic stroke, World J Emerg Med, v. 8, n. 6, p. 34-38, 2017.
GEORGE, P. M., et al. Novel Stroke Therapeutics: Unraveling Stroke Pathophysiology and Its Impact on Clinical Treatments, Neuron, v. 87, n. 7, p. 297-309, 2015.
LIU, F., et al. Mitochondria in Ischemic Stroke: New Insight and Implications, Aging Dis, v. 9, n. 8, p. 924-937, 2018.
RITZEL, R. M., et al. Functional differences between microglia and monocytes after ischemic stroke, J Neuroinflammation, v. 12, n. 9, p. 106, 2015.
TVRDIK, P., et al. In Vivo Imaging of Microglial Calcium Signaling in Brain Inflammation and Injury, Int J Mol Sci, v. 18, n. 10, p. 2017.
ANRATHER, J., et al. Inflammation and Stroke: An Overview, Neurotherapeutics, v. 13, n. 11, p. 661-670, 2016.
KAPOOR, V., et al. An introduction to PET-CT imaging, Radiographics, v. 24, n. 12, p. 523-543, 2004.
PHELPS, M. E., et al. Application of annihilation coincidence detection to transaxial reconstruction tomography, J Nucl Med, v. 16, n. 13, p. 210-224, 1975.
GARIBOTTO, V., et al. Clinical applications of hybrid PET/MRI in neuroimaging, Clin Nucl Med, v. 38, n. 14, p. e13-18, 2013.
NASRALLAH, I., et al. An overview of PET neuroimaging, Semin Nucl Med, v. 43, n. 15, p. 449-461, 2013.
SOKOLOFF, L. Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose, J Cereb Blood Flow Metab, v. 1, n. 16, p. 7-36, 1981.
ALBANO, D., et al. 18F-FDG PET/CT in primary brain lymphoma, J Neurooncol, v. 136, n. 17, p. 577-583, 2018.
DRZEZGA, A., et al. 18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis, J Nucl Med, v. 40, n. 18, p. 737-746, 1999.
MARCUS, C., et al. Brain PET in the diagnosis of Alzheimer's disease, Clin Nucl Med, v. 39, n. 19, p. e413-422; quiz e423-416, 2014.
SHIVAMURTHY, V. K., et al. Brain FDG PET and the diagnosis of dementia, AJR Am J Roentgenol, v. 204, n. 20, p. W76-85, 2015.
STAFFARONI, A. M., et al. The functional neuroanatomy of verbal memory in Alzheimer's disease: [(18)F]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) correlates of recency and recognition memory, J Clin Exp Neuropsychol, v. 39, n. 21, p. 682-693, 2017.
TRIPATHI, M., et al. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT, Neuroradiol J, v. 27, n. 22, p. 13-21, 2014.
YU, S., et al. 2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-D-pyranoside, an analog of salidroside, contributes to neuroprotection in cerebral ischemic injury in vitro and in vivo, Neuroreport, v. 29, n. 71, p. 426-431, 2018.
ZHANG, T., et al. Modular architecture of metabolic brain network and its effects on the spread of perturbation impact, Neuroimage, v. 186, n. 24, p. 146-154, 2019.
LOTAN, E., et al. Brain 18F-FDG-PET: Utility in the Diagnosis of Dementia and Epilepsy, Isr Med Assoc J, v. 22, n. 25, p. 178-184, 2020.
LIANG, S., et al. Abnormal Metabolic Connectivity in Rats at the Acute Stage of Ischemic Stroke, Neuroscience bulletin, v. 34, n. 26, p. 715-724, 2018.
BROUNS, R., et al. The complexity of neurobiological processes in acute ischemic stroke, Clin Neurol Neurosurg, v. 111, n. 27, p. 483-495, 2009.
SOBRADO, M., et al. Longitudinal studies of ischemic penumbra by using 18F-FDG PET and MRI techniques in permanent and transient focal cerebral ischemia in rats, Neuroimage, v. 57, n. 28, p. 45-54, 2011.
WU, J., et al. Roles of electro-acupuncture in glucose metabolism as assessed by 18F-FDG/PET imaging and AMPKα phosphorylation in rats with ischemic stroke, Int J Mol Med, v. 40, n. 29, p. 875-882, 2017.
WANG, J., et al. PET demonstrates functional recovery after transplantation of induced pluripotent stem cells in a rat model of cerebral ischemic injury, J Nucl Med, v. 54, n. 30, p. 785-792, 2013.
ZHANG, H., et al. Spatiotemporal PET Imaging of Dynamic Metabolic Changes After Therapeutic Approaches of Induced Pluripotent Stem Cells, Neuronal Stem Cells, and a Chinese Patent Medicine in Stroke, J Nucl Med, v. 56, n. 31, p. 1774-1779, 2015.
HAN, L., et al. Human Urinary Kallidinogenase Promotes Angiogenesis and Cerebral Perfusion in Experimental Stroke, PLoS One, v. 10, n. 32, p. e0134543, 2015.
HUI, Z., et al. Panaxatriol saponins promotes angiogenesis and enhances cerebral perfusion after ischemic stroke in rats, BMC Complement Altern Med, v. 17, n. 33, p. 70, 2017.
HWANG, H., et al. Improving Cerebral Blood Flow Through Liposomal Delivery of Angiogenic Peptides: Potential of ¹⁸F-FDG PET Imaging in Ischemic Stroke Treatment, J Nucl Med, v. 56, n. 34, p. 1106-1111, 2015.
BENTOURKIA, M., et al. Comparison of regional cerebral blood flow and glucose metabolism in the normal brain: effect of aging, J Neurol Sci, v. 181, n. 35, p. 19-28, 2000.
POURHASSAN SHAMCHI, S., et al. Normal patterns of regional brain (18)F-FDG uptake in normal aging, Hell J Nucl Med, v. 21, n. 36, p. 175-180, 2018.
TURPIN, S., et al. Modeling the Effects of Age and Sex on Normal Pediatric Brain Metabolism Using (18)F-FDG PET/CT, J Nucl Med, v. 59, n. 37, p. 1118-1124, 2018.
CAO, G., et al. YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice, Drug Des Devel Ther, v. 10, n. 38, p. 315-325, 2016.
CHOI, K. H., et al. Alpha-lipoic acid treatment is neurorestorative and promotes functional recovery after stroke in rats, Mol Brain, v. 8, n. 39, p. 9, 2015.
DENG, L., et al. Protective effect of hydroxysafflor yellow A alone or in combination with acetylglutamine on cerebral ischemia reperfusion injury in rat: A PET study using (18)F-fuorodeoxyglucose, Eur J Pharmacol, v. 825, n. 40, p. 119-132, 2018.
DONG, W., et al. Delayed administration of the GLP-1 receptor agonist liraglutide improves metabolic and functional recovery after cerebral ischemia in rats, Neurosci Lett, v. 641, n. 41, p. 1-7, 2017.
JOYA, A., et al. PET Imaging of Crossed Cerebellar Diaschisis after Long-Term Cerebral Ischemia in Rats, Contrast Media Mol Imaging, v. 2018, n. 42, p. 2483078, 2018.
LI, Y. Y., et al. Effects of constraint-induced movement therapy on brain glucose metabolism in a rat model of cerebral ischemia: a micro PET/CT study, Int J Neurosci, v. 128, n. 43, p. 736-745, 2018.
SUH, J. Y., et al. Hyperoxia-Induced ΔR(1), Stroke, v. 49, n. 44, p. 3012-3019, 2018.
SVOBODA, J., et al. Strain differences in intraluminal thread model of middle cerebral artery occlusion in rats, Physiol Res, v. 68, n. 45, p. 37-48, 2019.
XU, H., et al. 2-(4-Methoxyphenyl)Ethyl-2-Acetamido-2-Deoxy-β-D-Pyranoside Exerts a Neuroprotective Effect through Regulation of Energy Homeostasis and O-GlcNAcylation, J Mol Neurosci, v. 69, n. 46, p. 177-187, 2019.
YU, S., et al. 2-(4-Methoxyphenyl)ethyl-2-Acetamido-2-deoxy-β-d-pyranoside (A Salidroside Analog) Confers Neuroprotection with a Wide Therapeutic Window by Regulating Local Glucose Metabolism in a Rat Model of Cerebral Ischemic Injury, Neuroscience, v. 391, n. 47, p. 60-72, 2018.
ARNBERG, F., et al. Imaging of a clinically relevant stroke model: glucose hypermetabolism revisited, Stroke, v. 46, n. 48, p. 835-842, 2015.
BACKES, H., et al. Glucose consumption of inflammatory cells masks metabolic deficits in the brain, Neuroimage, v. 128, n. 49, p. 54-62, 2016.
CLAUSEN, B. H., et al. Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signaling., Scientific Reports, v. n. 51, p. 6, 2016.
YU, S., et al. Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke, Neuroscience, v. 327, n. 50, p. 44-52, 2016.
BAI, J., et al. Effect of Pei Yuan Tong Nao capsules on neuronal function and metabolism in cerebral ischemic rats, Journal of Ethnopharmacology, v. 238, n. 52, p. 111837, 2019.
CHEVIN, M., et al. Benefits of hypothermia in neonatal arterial ischemic strokes: A preclinical study, Int J Dev Neurosci, v. 80, n. 53, p. 257-266, 2020.
ODORCYK, F. K., et al. Differential glucose and beta-hydroxybutyrate metabolism confers an intrinsic neuroprotection to the immature brain in a rat model of neonatal hypoxia ischemia, Exp Neurol, v. 330, n. 54, p. 113317, 2020.
OUYANG, Y., et al. Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia, J Vis Exp, v. n. 55, p. 2015.
LIU, N., et al. Evolutional characterization of photochemically induced stroke in rats: a multimodality imaging and molecular biological study., Transl Stroke Res, v. 8, n. 70, p. 244-256., 2016.
CARMICHAEL, S. T. Rodent models of focal stroke: size, mechanism, and purpose, NeuroRx, v. 2, n. 56, p. 396-409, 2005.
MCCABE, C., et al. Animal models of ischaemic stroke and characterisation of the ischaemic penumbra, Neuropharmacology, v. 134, n. 57, p. 169-177, 2018.
KANEMITSU, H., et al. Differences in the extent of primary ischemic damage between middle cerebral artery coagulation and intraluminal occlusion models, J Cereb Blood Flow Metab, v. 22, n. 58, p. 1196-1204, 2002.
KITAGAWA, K., et al. Cerebral ischemia after bilateral carotid artery occlusion and intraluminal suture occlusion in mice: evaluation of the patency of the posterior communicating artery, J Cereb Blood Flow Metab, v. 18, n. 59, p. 570-579, 1998.
ARNBERG, F., et al. Image-guided method in the rat for inducing cortical or striatal infarction and for controlling cerebral blood flow under MRI, Stroke, v. 43, n. 60, p. 2437-2443, 2012.
GERRIETS, T., et al. The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats, J Neurosci Methods, v. 122, n. 61, p. 201-211, 2003.
DINAPOLI, V. A., et al. Selective MCA occlusion: a precise embolic stroke model, J Neurosci Methods, v. 154, n. 62, p. 233-238, 2006.
ZHANG, R. L., et al. A rat model of focal embolic cerebral ischemia, Brain Res, v. 766, n. 63, p. 83-92, 1997.
GREGERSEN, R., et al. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice, J Cereb Blood Flow Metab, v. 20, n. 64, p. 53-65, 2000.
LAMBERTSEN, K. L., et al. A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice, J Cereb Blood Flow Metab, v. 25, n. 65, p. 119-135, 2005.
NI, R., et al. In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI, Mol Imaging Biol, v. 24, n. 73, p. 700-709, 2022.
HE, W., et al. Feature-based Quality Assessment of Middle Cerebral Artery Occlusion Using 18F-Fluorodeoxyglucose Positron Emission Tomography, Neurosci Bull, v. 38, n. 72, p. 1057-1068, 2022.
RUMAJOGEE, P., et al. Rodent Hypoxia–Ischemia Models for Cerebral Palsy Research: A Systematic Review, Frontiers in Neurology, v. 7, n. 66, p. 2016.
GENNARO, M., et al. Rodent Models of Developmental Ischemic Stroke for Translational Research: Strengths and Weaknesses, Neural Plast, v. 2019, n. 67, p. 5089321, 2019.
LEÓN-MORENO, L. C., et al. Challenges and Improvements of Developing an Ischemia Mouse Model Through Bilateral Common Carotid Artery Occlusion, J Stroke Cerebrovasc Dis, v. 29, n. 68, p. 104773, 2020.
KRÄMER, S. D., et al. Changes of cerebral network activity after invasive stimulation of the mesencephalic locomotor region in a rat stroke model, Exp Neurol, v. 347, n. 74, p. 113884, 2022.
KRÄMER, S. D., et al. Deep Brain Stimulation in the Subthalamic Nucleus Can Improve Skilled Forelimb Movements and Retune Dynamics of Striatal Networks in a Rat Stroke Model, International Journal of Molecular Sciences, v. 23, n. 75, p. 15862, 2022.
PRANDO, S., et al. Methods for quantification of cerebral glycolytic metabolism using 2-deoxy-2-[18 F]fluoroglucose in small animals., Res Biomed Eng, v. 34, n. 69, p. 254-272., 2018.
Published
Issue
Section
License
Copyright (c) 2023 Brazilian Journal of Radiation Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing: The BJRS articles are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
How to Cite
